Pro members get actionable news alerts up to 30 minutes before other traders — Get our lowest prices
Pro members get actionable news alerts up to 30 minutes before other traders — Get our lowest prices
Sorrento Therapeutics Inc has a consensus price target of $12.5 based on the ratings of 2 analysts. The high is $20 issued by HC Wainwright & Co. on March 25, 2022. The low is $5 issued by Cantor Fitzgerald on November 2, 2022. The 2 most-recent analyst ratings were released by Cantor Fitzgerald and HC Wainwright & Co. on November 2, 2022 and March 25, 2022, respectively. With an average price target of $12.5 between Cantor Fitzgerald and HC Wainwright & Co., there's an implied 208233.33% upside for Sorrento Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Sorrento Therapeutics (OTCEM:SRNE) was reported by Cantor Fitzgerald on November 2, 2022. The analyst firm set a price target for $5.00 expecting SRNE to rise to within 12 months (a possible 83233.33% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Sorrento Therapeutics (OTCEM:SRNE) was provided by Cantor Fitzgerald, and Sorrento Therapeutics initiated their overweight rating.
There is no last upgrade for Sorrento Therapeutics
There is no last downgrade for Sorrento Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sorrento Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sorrento Therapeutics was filed on November 2, 2022 so you should expect the next rating to be made available sometime around November 2, 2023.
While ratings are subjective and will change, the latest Sorrento Therapeutics (SRNE) rating was a initiated with a price target of $0.00 to $5.00. The current price Sorrento Therapeutics (SRNE) is trading at is $0.01, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.